Eagle Bay Advisors LLC
- SEC CIK
- 0001862864
- Latest filing
- Aug 3, 2026
SUPN holding history
Supernus Pharmaceuticals, Inc. in every 13F filed by Eagle Bay Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SUPN overviewAll 13F holders of SUPNFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −156−100.0% | Sold out | Holders |
| Q4 2024 | 156 | $5.64K | <0.1% | +7+4.7% | Added | Holders |
| Q3 2024 | 149 | $4.65K | <0.1% | −80−34.9% | Reduced | Holders |
| Q2 2024 | 229 | $6.13K | <0.1% | −56−19.6% | Reduced | Holders |
| Q1 2024 | 285 | $9.72K | <0.1% | −116−28.9% | Reduced | Holders |
| Q4 2023 | 401 | $11.6K | <0.1% | −2,811−87.5% | Reduced | Holders |
| Q3 2023 | 3,212 | $88.6K | <0.1% | +984+44.2% | Added | Holders |
| Q2 2023 | 2,228 | $67.0K | <0.1% | −572−20.4% | Reduced | Holders |
| Q1 2023 | 2,800 | $101.4K | 0.1% | −386−12.1% | Reduced | Holders |
| Q4 2022 | 3,186 | $113.6K | 0.1% | +515+19.3% | Added | Holders |
| Q3 2022 | 2,671 | $91.0K | 0.1% | +8+0.3% | Added | Holders |
| Q2 2022 | 2,663 | $77.0K | <0.1% | +1,567+143.0% | Added | Holders |
| Q1 2022 | 1,096 | $35.0K | <0.1% | −348−24.1% | Reduced | Holders |
| Q4 2021 | 1,444 | $42.0K | <0.1% | +750+108.1% | Added | Holders |
| Q3 2021 | 694 | $18.0K | <0.1% | −489−41.3% | Reduced | Holders |
| Q2 2021 | 1,183 | $39.0K | <0.1% | – | No prior filing | Holders |